Ardelyx, Inc. (ARDX)
NASDAQ · Manufacturing · Pharmaceutical preparations
ARDX price, last 12 months
Key stats
- Previous close
- $3.45
- Open
- $3.47
- Day range
- $3.40 – $3.49
- 52-week range
- $3.33 – $8.40
- Volume
- 2.1M
- Avg volume (20 days)
- 4.2M
- Market cap
- $883.0M
Performance
Technicals and fundamentals
About Ardelyx, Inc.
Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. Its products Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $883.0M